As part of the Technology and Innovation Centre at the University of Strathclyde, the CMAC vision is to accelerate the adoption of continuous manufacturing and crystallisation processes, systems and plants for the production of high-value chemical products; improving their quality at lower costs, more quickly and sustainably. The aim is to create an effective partnership with industry, academia and public bodies.
GSK, Novartis, AstraZeneca and Bayer are tier 1 members, with technology companies also playing an important role. The physical hub is at Strathclyde University with Glasgow, Heriot-Watt, Edinburgh, Cambridge, Loughborough and Bath Universities contributing to an exceptional multi-disciplinary academic team.
From initial funding from Scottish Funding Council more than £80m has been raised from various sources. The key research platform is the EPRSC National Centre for Innovative Manufacturing in Continuous Manufacturing and Crystallisation. Recently an EPSRC doctoral training centre was secured which provides a further forty five PhD students across the network.
Find out more
Technology & Innovation Centre (Main Entrance)
99 George Street
TIC Main Reception
+44 (0) 141 444 7000